Pierre Geslin
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
- Epidemiology 10
- Pneumonia and Respiratory Infections 10
- Pneumocystis jirovecii pneumonia detection and treatment 2
-
- Antimicrobial Resistance in Staphylococcus 3
- Otolaryngology and Infectious Diseases 1
- Co-authors
- Didier Guillemot (1 shared paper)F Vauzelle-Kervroëdan (1 shared paper)Claude Carbón (1 shared paper)Beverley Balkau (1 shared paper)G Bouvenot (1 shared paper)Eveline Eschwège (1 shared paper)Édouard Bingen (7 shared papers)C. Doit (6 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (5 papers)Advances in experimental medicine and biology (2 papers)Journal of Clinical Microbiology (1 paper)JAMA (1 paper)The Journal of Infectious Diseases (1 paper)
- Partner nations
- FranceGermanySwitzerland
In The Last Decade
Pierre Geslin
12 papers receiving 616 citations
Peers
Comparison fields: 5 of 62
- Applied Microbiology and Biotechnology 166
- Molecular Medicine 109
- Microbiology 110
- Epidemiology 372
- Otorhinolaryngology 37
Countries citing papers authored by Pierre Geslin
This map shows the geographic impact of Pierre Geslin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Geslin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Geslin more than expected).
Fields of papers citing papers by Pierre Geslin
This network shows the impact of papers produced by Pierre Geslin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Geslin. The network helps show where Pierre Geslin may publish in the future.
Co-authors
The 25 scholars most cited alongside Pierre Geslin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 440 | |
| 2 | 2001 | 40 | |
| 3 | 1999 | 40 | |
| 4 | 1996 | 33 | |
| 5 | 2002 | 28 | |
| 6 | 2000 | 25 | |
| 7 | 1998 | 23 | |
| 8 | 1999 | 12 | |
| 9 | 1997 | 9 | |
| 10 | 1995 | 6 | |
| 11 | 2003 | 4 | |
| 12 | 1997 | 1 |
About Pierre Geslin
Pierre Geslin is a scholar working on Epidemiology, Infectious Diseases, Microbiology, Pharmacology and Public Health, Environmental and Occupational Health, having authored 12 papers that have together received 661 indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (10 papers), Bacterial Infections and Vaccines (5 papers), Streptococcal Infections and Treatments (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Bacterial Identification and Susceptibility Testing (2 papers) and Otolaryngology and Infectious Diseases (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (166 citations), Molecular Medicine (109 citations), Microbiology (110 citations), Epidemiology (372 citations) and Otorhinolaryngology (37 citations). Pierre Geslin has collaborated with scholars based in France, Germany and Switzerland. Frequent co-authors include Didier Guillemot, F Vauzelle-Kervroëdan, Claude Carbón, Beverley Balkau, G Bouvenot, Eveline Eschwège, Édouard Bingen, C. Doit, F. Fitoussi and Chawki Loukil. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Advances in experimental medicine and biology, Journal of Clinical Microbiology, JAMA and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.